US 11213526
Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
granted A61KA61K31/437A61K31/444
Quick answer
US patent 11213526 (Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/437, A61K31/444, A61K31/513, A61K31/567